SYSTEMATIC REVIEW article
Front. Cardiovasc. Med.
Sec. Coronary Artery Disease
Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1596208
Comparison of different timings of percutaneous coronary intervention in patients with transcatheter aortic valve implantation: a network meta-analysis
Provisionally accepted
- Inner Mongolia Forestry General Hospital, Yakeshi, Inner Mongolia Autonomous Region, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background:The combination of selective percutaneous coronary intervention(PCI)and transcatheter aortic valve implantation(TAVI)is a safe and feasible therapy and has become our preferred treatment option for patients with severe aortic stenosis and high-risk coronary heart disease.However, the timing of staged PCI is uncertain.The purpose of this meta-analysis is to compare the benefits and risks of TAVI alone,PCI before TAVI,simultaneous TAVI and PCI,and PCI after TAVI in TAVI patients, and to provide guidance for clinical decision-making on the timing of PCI in TAVI patients.Methods:We searched Pubmed,Embase, the Cochrane Library and Web of Science as of April 2025.By employing Bayesian network meta-analysis, with the aid of R software (V4.3.2) and in combination with Stata (V15),the analysis included outcomes such as all-cause mortality, cardiovascular mortality, stroke, bleeding and myocardial infarction (MI).Pooled analysis was performed utilizing risk ratios(RR)and 95% confidence intervals (CI).Results:A total of 13 studies involving 304,181 patients were included in the analysis.The research findings showed that the application of TAVI alone significantly reduced the all-cause mortality compared to PCI after TAVI(RR=0.35, 95%CrI: 0.13, 0.88),and the lowest all-cause mortality rate was observed in the cumulative ranking(SUCRA=75.89%).Compared with PCI after TAVI(RR=0.57, 95%CrI: 0.41, 0.79)and TAVIplus PCI(RR=0.72, 95%CrI: 0.54, 0.97),PCI before TAVI significantly reduced cardiovascular mortality and was found the lowest cardiovascular mortality in the cumulative ranking (SUCRA=98.37%).In comparison to TAVIplus PCI(RR=0.44, 95%CrI: 0.27, 0.71),PCI after TAVI significantly reduced the stroke rate and found the lowest stroke rate in the cumulative ranking(SUCRA=97.21%).The application of TAVI alone significantly reduced the bleeding rate compared to TAVIplusPCI (RR=0.61, 95%CrI: 0.60, 0.62),and the lowest bleeding rate was observed in the cumulative ranking (SUCRA=88.14%).Compared with PCI before TAVI(RR=0.12, 95%CrI: 0.04, 0.29)and TAVI (RR=0.21, 95%CrI: 0.12, 0.34), TAVIplusPCI significantly reduced the incidence of myocardial infarction and was found the lowest incidence of myocardial infarction in the cumulative ranking(SUCRA=96.44%).Conclusion:The timing of application of TAVI combined with PCI affects mortality and the incidence of cardiovascular events.Among them,PCI after TAVI may effectively reduce all-cause mortality, cardiovascular mortality, and stroke, but the interval between the two procedures remains uncertain. Future studies should investigate the optimal interval between PCI and TAVI to maximize clinical benefits.
Keywords: CAD, TAVI, PCI, Mortality, Network meta-analysis
Received: 19 Mar 2025; Accepted: 27 Jun 2025.
Copyright: © 2025 Wen, Yang, Xu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jiuyu Yang, Inner Mongolia Forestry General Hospital, Yakeshi, 022 150, Inner Mongolia Autonomous Region, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.